{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:11056"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:11056","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The role of myocardial fibrosis in outcome following mitral valve repair in degenerative mitral regurgitation","abstract":"Primary degenerative mitral regurgitation (MR) is a disease of increasing prevalence. Its optimal management is surgical repair, but surgery timings remain controversial. Current guidelines that suggest ‘watchful-waiting’ have been criticised for promoting rescue surgery after the establishment of symptoms or left ventricular (LV) dysfunction. Conversely, non-selective early surgical approaches result in unnecessary surgery for some patients. Myocardial fibrosis has been hypothesised to accumulate in MR, leading to eventual overt LV dysfunction. This thesis examines this hypothesis, assesses the prognostic impact of myocardial fibrosis, and determines its value as a biomarker for optimising the timing of surgery. In a prospective multicentre study of severe MR patients, I provide definitive histological evidence for the presence of myocardial fibrosis, before the onset of symptoms. Due to its patchy nature, non-invasive quantification of fibrosis on cardiac magnetic resonance (CMR) was a superior marker of preoperative myocardial function and symptom burden. However, neither histology- nor CMR-derived fibrosis correlated with postoperative outcomes. Despite successful surgery, symptomatic patients continued to possess worse cardiopulmonary exercise (CPET) performance and symptom burden quantified via patient-response questionnaires (PROMs) compared to asymptomatic patients, providing additional support for the benefits of early surgery. Further evaluation of surveillance CPET and PROMs is indicated for patients in whom early surgery is clinically inappropriate.","abstract_html":"Primary degenerative mitral regurgitation (MR) is a disease of increasing prevalence. Its optimal management is surgical repair, but surgery timings remain controversial. Current guidelines that suggest ‘watchful-waiting’ have been criticised for promoting rescue surgery after the establishment of symptoms or left ventricular (LV) dysfunction. Conversely, non-selective early surgical approaches result in unnecessary surgery for some patients. Myocardial fibrosis has been hypothesised to accumulate in MR, leading to eventual overt LV dysfunction. This thesis examines this hypothesis, assesses the prognostic impact of myocardial fibrosis, and determines its value as a biomarker for optimising the timing of surgery. In a prospective multicentre study of severe MR patients, I provide definitive histological evidence for the presence of myocardial fibrosis, before the onset of symptoms. Due to its patchy nature, non-invasive quantification of fibrosis on cardiac magnetic resonance (CMR) was a superior marker of preoperative myocardial function and symptom burden. However, neither histology- nor CMR-derived fibrosis correlated with postoperative outcomes. Despite successful surgery, symptomatic patients continued to possess worse cardiopulmonary exercise (CPET) performance and symptom burden quantified via patient-response questionnaires (PROMs) compared to asymptomatic patients, providing additional support for the benefits of early surgery. Further evaluation of surveillance CPET and PROMs is indicated for patients in whom early surgery is clinically inappropriate.","abstract_has_math":false,"creators":["Liu, Boyang"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-11","date_published":"2020-11","updated_at":"2026-11-19T09:31:15Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["PG/14/74/31056"],"render_values":[{"text":"PG/14/74/31056","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/11056/1/Liu2020PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A11056","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["british_heart_foundation"]},{"key":"dc:creator","label":"Author","values":["Liu, Boyang"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-11-25"]},{"key":"dc:date.issued","label":"Date","values":["2020-11"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/11056/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["PG/14/74/31056"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/11056/1/Liu2020PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Primary degenerative mitral regurgitation (MR) is a disease of increasing prevalence. Its optimal management is surgical repair, but surgery timings remain controversial. Current guidelines that suggest ‘watchful-waiting’ have been criticised for promoting rescue surgery after the establishment of symptoms or left ventricular (LV) dysfunction. Conversely, non-selective early surgical approaches result in unnecessary surgery for some patients. Myocardial fibrosis has been hypothesised to accumulate in MR, leading to eventual overt LV dysfunction. This thesis examines this hypothesis, assesses the prognostic impact of myocardial fibrosis, and determines its value as a biomarker for optimising the timing of surgery. In a prospective multicentre study of severe MR patients, I provide definitive histological evidence for the presence of myocardial fibrosis, before the onset of symptoms. Due to its patchy nature, non-invasive quantification of fibrosis on cardiac magnetic resonance (CMR) was a superior marker of preoperative myocardial function and symptom burden. However, neither histology- nor CMR-derived fibrosis correlated with postoperative outcomes. Despite successful surgery, symptomatic patients continued to possess worse cardiopulmonary exercise (CPET) performance and symptom burden quantified via patient-response questionnaires (PROMs) compared to asymptomatic patients, providing additional support for the benefits of early surgery. Further evaluation of surveillance CPET and PROMs is indicated for patients in whom early surgery is clinically inappropriate."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["The role of myocardial fibrosis in outcome following mitral valve repair in degenerative mitral regurgitation"]}]}],"canonical_facts":{"dc:contributor.sponsor":["british_heart_foundation"],"dc:creator":["Liu, Boyang"],"dc:date":["2020-11-25"],"dc:date.issued":["2020-11"],"dc:description.abstract":["Primary degenerative mitral regurgitation (MR) is a disease of increasing prevalence. Its optimal management is surgical repair, but surgery timings remain controversial. Current guidelines that suggest ‘watchful-waiting’ have been criticised for promoting rescue surgery after the establishment of symptoms or left ventricular (LV) dysfunction. Conversely, non-selective early surgical approaches result in unnecessary surgery for some patients. Myocardial fibrosis has been hypothesised to accumulate in MR, leading to eventual overt LV dysfunction. This thesis examines this hypothesis, assesses the prognostic impact of myocardial fibrosis, and determines its value as a biomarker for optimising the timing of surgery. In a prospective multicentre study of severe MR patients, I provide definitive histological evidence for the presence of myocardial fibrosis, before the onset of symptoms. Due to its patchy nature, non-invasive quantification of fibrosis on cardiac magnetic resonance (CMR) was a superior marker of preoperative myocardial function and symptom burden. However, neither histology- nor CMR-derived fibrosis correlated with postoperative outcomes. Despite successful surgery, symptomatic patients continued to possess worse cardiopulmonary exercise (CPET) performance and symptom burden quantified via patient-response questionnaires (PROMs) compared to asymptomatic patients, providing additional support for the benefits of early surgery. Further evaluation of surveillance CPET and PROMs is indicated for patients in whom early surgery is clinically inappropriate."],"dc:format":["text"],"dc:identifier.grantnumber":["PG/14/74/31056"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/11056/1/Liu2020PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/11056/"],"dcterms:accessrights":["public"],"dc:title":["The role of myocardial fibrosis in outcome following mitral valve repair in degenerative mitral regurgitation"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:31:15Z"}